Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Artemether-lumefantrine efficacy study for uncomplicated falciparum malaria in India
ACTRN12614000765628Phase 4Recruiting
- Sponsor
- Indian Council of Medical Research
- Start
- Jun 2014
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, open-label, single-arm trial of artemether and lumefantrine in Malaria, sponsored by Indian Council of Medical Research. Primary endpoint: Treatment outcome classification. Started Jun 2014; status: recruiting.
02
Drugs
artemetherlumefantrine
03
Conditions
Malaria
Beyond the preview
Go deeper on ACTRN12614000765628.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ACTRN12614000765628.